Secondary Adjuvant Treatment for Patients With Isolated Tumor Cells in Bone Marrow

NCT00248703 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
1128
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Oslo University Hospital

Collaborators